YellowGrade
Emergent to make Calgary-based Providence Therapeutics' potential COVID-19 vaccine

Sept. 14, 2021, 9:12 a.m.

(CBC News) Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million.

Login to grade this article.